featured
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin Induction for Untreated Brain Metastases From Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial
JAMA Oncol 2023 Dec 21;[EPub Ahead of Print], TW Chen, MS Dai, LM Tseng, SC Chen, TY Chao, TC Chao, YC Chang, CF Chiu, CT Liu, CH Lin, CY Liu, YF Chen, DY Chang, JC Yu, KM Rau, YY Hsieh, SC Shen, SM Huang, AL Cheng, YS LuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.